Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 49 (RPL36AP49)

Target: RPL36AP49
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L36a pseudogene 49 (RPL36AP49) is a processed pseudogene in the human genome. It does not encode a functional protein and does not act as a therapeutic target. Pseudogenes are typically non-coding genomic sequences that resemble protein-coding genes but are nonfunctional due to accumulated mutations. RPL36AP49 specifically derives from the ribosomal protein L36a (RPL36A) gene family, for which multiple pseudogenes exist throughout the genome. RPL36AP49 is correctly named and referenced as a pseudogene, but it is important to note that it is not a druggable target and has no known biological or therapeutic function.

Other names: RPL36A_23_1584RPL36AP49

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 49 (RPL36AP49).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 49 (RPL36AP49).

Explore the full profile